Dr. Patrick Rynn Hogan, DHA, is a healthcare executive, scholar, and author specializing in public health, health systems resilience, artificial intelligence, and global risk. Holding a Doctor of Health Administration, he has extensive experience across healthcare delivery, population health analytics, employer-sponsored health strategy, and health technology innovation. As CEO and Co-Founder of Prescient Healthcare, he leads an AI-enabled decision intelligence platform that functions as a virtual “Chief Medical Officer” for self-insured employers and public-sector organizations. The platform integrates clinical, claims, and workforce data to detect emerging health risks early, quantify economic impacts, and drive evidence-based interventions that reduce avoidable utilization and improve workforce outcomes, with a strong emphasis on explainable AI, governed analytics, and real-world applicability.
Dr. Hogan also serves as Board Chair of Celbridge Science, advancing non-animal methods and in-silico analytics to reduce reliance on animal testing in biomedical research through partnerships with academic institutions and the National Institutes of Health. His career includes leadership roles in healthcare consulting, digital health, and analytics, focusing on clinical workflows, population health management, and enterprise data platforms while addressing systemic vulnerabilities such as workforce shortages and misaligned incentives during crises. He is the author of The Silent Pandemic of Antimicrobial Resistance: Why the Next Global Health Crisis Has Already Begun, which examines antimicrobial resistance as a systemic threat exposing weaknesses in medicine, governance, and global cooperation, advocating integrated solutions across science, policy, and operations for interconnected challenges like pandemic preparedness and chronic disease.